Robotic Surgery for Gastrointestinal (GI) Malignancies

Dear Colleagues,

Robotic-assisted surgery for GI malignancies, including colorectal, upper GI, liver, and pancreas, has become common practice in many centers around the world. As more robotic platforms are introduced into practice, costs are being driven down, and the field of minimally invasive surgical oncology is being revolutionized at a fast-growing pace.

Surgical robots have been in use for almost two decades, though there are very little data showing any advantages to laparoscopy. Having said that, in the last couple of years, there has been a rise in high-quality academic studies that have shown measurable advantages in robotic surgery in terms of metrics such as length of stay, SSI, readmissions, conversion rates, lower rates of complications, and the wellbeing of the patient and the surgeon.

Operating on different GI malignancies requires specialized training, and so does minimally invasive surgery. Some disciplines have adopted robotic surgery full-heartedly, like colorectal surgery, valuing the robotic approach for pelvic surgery, and others are still learning where and how to utilize these robotic platforms, as is the case in liver and pancreas surgery.

This Special Issue of Cancers will investigate the role of robotic surgery in treating various gastrointestinal cancers and will feature new articles and reviews focused on the implementation of robotic surgery, "how to do it", and its advantages.

Dr. Yaron Rudnicki
Prof. Dr. Shmuel R. Avital
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

• robotic surgery
• colorectal cancer
• gastric cancer
• liver cancer
• pancreatic cancer
• esophageal cancer
• robotic platform